trial · primary record
NRL-1049
Cerebral Cavernous Malformation
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-05-26 |
| Primary endpoint | Safety and tolerability: Treatment-emergent adverse events (TEAEs) |
| Registry ID | NCT07908134 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:19.796Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908134
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.